首页> 外文期刊>World Journal of Surgical Oncology >Control values of ovarian cancer tumor markers and standardisation of a protocol for sampling peritoneal fluid and performing washing during laparoscopy
【24h】

Control values of ovarian cancer tumor markers and standardisation of a protocol for sampling peritoneal fluid and performing washing during laparoscopy

机译:卵巢癌肿瘤标志物的控制值和腹腔镜检查期间腹膜液采样和冲洗协议的标准化

获取原文
获取外文期刊封面目录资料

摘要

Background Determination of the tumor marker concentration in peritoneal fluid (PF) may help to assess its potential to detect small concentration changes between benign ovarian pathology and early stage ovarian cancer. Peritoneal washing, which can also be obtained when PF is absent, is already included in the International Federation of Gynecology and Obstetrics (FIGO) staging classification for ovarian cancer but sampling has not yet been standardized. Since our aim was to evaluate the relationship between marker concentration in PF and washing, standardization of the sampling protocol was a prerequisite to ensure reliable results. Methods Thirty-three women with non-malignant pathology of the reproductive organs were included in the study. We used three promising tumor markers for evaluation of the marker concentration in local fluid: osteopontin (sOPN), splice variant 6 of sCD44 (sCD44-v6) and vascular cell adhesion molecule-1 (sVCAM-1). After aspiration of PF, washing of the uterus, ovaries and pelvic peritoneum was performed with saline solution. Patients were divided into two groups based on the solution volume: A-20?ml and B-50?ml. To determine the efficiency of washing in relation to solution volume, washing was repeated three times. Concentrations of markers in samples were determined using flow cytometry. Results Mean concentrations of markers were significantly higher ( P Conclusions Our work demonstrates for the first time that concentrations of sOPN, sCD44-v6 and sVCAM-1 in PF correlate with peritoneal washing in women with non-malignant pathology of the reproductive organs. This indicates that, for selected tumor markers, washing can replace PF when PF is absent. A standardized protocol for sampling PF and performing washing during laparoscopy was established.
机译:背景腹膜液(PF)中肿瘤标志物浓度的测定可能有助于评估其检测良性卵巢病理和早期卵巢癌之间微小浓度变化的潜力。国际妇产科联合会(FIGO)卵巢癌分期分类中已经包括了腹膜清洗,当没有PF时也可以进行腹膜清洗,但采样尚未标准化。由于我们的目的是评估PF中标记物浓度与洗涤之间的关系,因此标准化采样方案是确保可靠结果的前提。方法将33例生殖器官非恶性病变的女性纳入研究。我们使用了三种有希望的肿瘤标志物来评估局部液体中的标志物浓度:骨桥蛋白(sOPN),sCD44的剪接变体6(sCD44-v6)和血管细胞粘附分子1(sVCAM-1)。抽吸PF后,用盐溶液冲洗子宫,卵巢和骨盆腹膜。根据溶液量将患者分为两组:A-20?ml和B-50?ml。为了确定相对于溶液体积的洗涤效率,重复洗涤3次。使用流式细胞仪确定样品中标志物的浓度。结果标志物的平均浓度显着较高(P结论我们的工作首次证明,在生殖器官非恶性病变的女性中,PF中的sOPN,sCD44-v6和sVCAM-1的浓度与腹膜冲洗有关。这表明对于选定的肿瘤标志物,当PF不存在时可以用PF代替PF,建立了腹腔镜检查过程中PF采样和冲洗的标准方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号